Results 1 - 10 of 30 : 1 2 3 Next
The drugmaker takes charges to get leaner.
Seattle Genetics Has What Others Want
Out-licensing its platform technology could mean big bucks.
3 Stocks Revving Their Engines
Investor sentiment is getting behind stocks that are set to run.
The Stocks the Funds Are Buying
Which funds are buying Wall Street's most wanted?
Actions speak louder than words.
The good outweighed the bad.
You can glean investing insights in unlikely places.
Start paying attention to it.
Soliris Brightens Alexion's Quarter
The pharmaceutical's lone drug posts gargantuan growth.
Will These Drugs Get FDA Approval?
Heads up, drug company investors.
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK